Tải bản đầy đủ (.pdf) (326 trang)

Tổng hợp và tính chất của một số Axetamidoaryl-1,3,4-Oxadiazol-2-Thiol

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (20.87 MB, 326 trang )



*********************




NGUYỄN THỊ SƠN








TỔNG HỢP VÀ TÍNH CHẤT CỦA MỘT SỐ
AXETAMIDOARYL-1,3,4-OXADIAZOL-2-THIOL




LUẬN ÁN TIẾN SỸ HÓA HỌC









Hà Nội - 2012

ĐẠI HỌC QUỐC GIA HÀ NỘI
TRƢỜNG ĐẠI HỌC KHOA HỌC TỰ NHIÊN




NGUYỄN THỊ SƠN





TỔNG HỢP VÀ TÍNH CHẤT CỦA MỘT SỐ
AXETAMIDOARYL-1,3,4-OXADIAZOL-2-THIOL

Chuyên ngành: Hóa Hữu cơ
Mã số: 62 44 27 01


LUẬN ÁN TIẾN SỸ HÓA HỌC


NGƢỜI HƢỚNG DẪN KHOA HỌC
PGS.TSKH. Lƣu Văn Bôi











- 2012




i


MỤC LỤC
 v
HÌNH vi
 ix
 1
         -
OXADIAZOL 3
1.1. -oxadiazol 3
 4
     -      
azometin 5
     -     
cacboxylic 7
-oxadiazol 10
-oxadiazol [97] 10
 12

-oxadiazol 13
--1,3,4-oxadiazol 13
-oxadiazol-2-thiol 16
1.3. -oxadiazol 24
 24
 25
1.3.3.  26
 30



ii
 30
-(axetamidoaryl)-1,3,4-oxadiazol-2-thiol (IVa-g) 38
2.2.1.  38
2.2.2. C-axetamidoaryl-1,3,4-oxadiazol-2-thiol (IVa-g) 40
2.3. 2-(N-arylcacboxamidometylthio)-5-(axetamidoaryl)-1,3,4-
oxadiazol 52
2.3.1. -(-axetamidoaryl)-1,3,4-oxadiazol-2--
cloaxetanilit 52

 58
      5-(axetamidoaryl)-1,3,4-oxadiazol-2-
-cloaxetanilit 68
2.3.4.        -(axetamidoaryl)-1,3,4-
oxadiazol-2-- 71
2.3.5.  2-(N-
arylcacboxamidometylthio)-5-(axetamidoaryl)-1,3,4-oxadiazol 77
 77
 78

 79
  . 79
2-(N-arylcacboxamidometylthio)-5-
(axetamidoaryl)-1,3,4-oxadiazol 87
          -(N-arylcacboxamido
metylthio)-5-(axetamidoaryl)-1,3,4- 107
 115
 115
 115



iii
  115
 116
 117
-cloaxetanilit 117
-amino-2-halogenobenzoic 117
-g) 118
-g) 119
benzoyl hidrazin (IIIa-g) 119
3.2.6.      -(axetamidoaryl)-1,3,4-oxadiazol-2-thiol
(IVa-g) 120
     -(axetamidoaryl)-1,3,4-oxadiazol-2-thiol (IVa-g)
-cloaxetanilit 121
3.3.1. Quy trình chung 121
3.3.2. 
 122
 122
   -axetamidophenyl-4-bromphenylaminothio

semicacbazit 122
     -axetamidophenyl-4-bromphenylamino
thiosemicacbazit 122
     -(axetamidoaryl)-1,3,4-oxadiazol-2-thiolat
 -cloaxetanilit 125
3.3.4. X           -arylamino-5-
(axetamidoaryl)-1,3,4-oxadiazol 127
     -(N-arylcacboxamidometylthio)-5-
(axetamidoaryl)-1,3,4-oxadiazol thành 2-arylamino-5-(axetamidoaryl)-
1,3,4-oxadiazol 127



iv
3.3.4.2. --axetamidoaryl)-1,3,4-oxadiazol-2-
4-bromanilin 128
--axetamidoaryl)-1,3,4-oxadiazol-2-
4-bromanilinua kali 128
           2-(N-
arylcacboxamidometylthio)-5-(axetamidoaryl)-1,3,4-oxadiazol 129
 129
 129
 130
 130
KẾT LUẬN 134
DANH MỤC CÁC CÔNG TRÌNH KHOA HỌC CỦA TÁC GIẢ LIÊN
QUAN ĐẾN LUẬN ÁN. Error! Bookmark not defined.
TÀI LIỆU THAM KHẢO 135
PHỤ LỤC - 1 -











v
DANH MỤC KÝ HIỆU CÁC CHỮ VIẾT TẮT

 
 
J 
s Singlet
dd Doublet of doublet
t Triplet
m Multiplet
br Broad (pic tù)
T
nc

0
C)
CTPT 
KLPT 
IR Infrared
NMR Nuclear magnetic resonance
MS Mass spectroscopy

HMBC Heteronuclear Multiplet-Bond Correlation
HSQC Heteronuclear Single Quantum Correlation
COSY Correlation Spectrocopy
MIC Minimum inhibition concentration.
TMTD Tetrametylthiuram disunfua
DMF N,N-dimetylfocmamit
HIV Human Immunodeficiency Virus
TLTK 



vi
DANH MỤC HÌNH
Hình 1.-oxadiazol 11
Hình 1.-
oxadiazol 11
Hình 1.--oxadiazol-2-thiol 12
Hình 1.4. -oxadiazol-2-thiolat và etylthiolat 16
Hình 1.     -(4-pyridin)-1,3,4-oxadiazol-2- 
Cu
2+
21
-(2-pyridin)-1,3,4-oxadiazol-2-
ion Hg
2+
,Cd
2+
; Zn
2+
21

Hình 1.      5-(3,4,5-trimetoxyphenyl)-1,3,4-
oxadiazol-2-thiol 24
Hình 2.1 32
Hình 2.2 34
Hình 2.3
1
H- 35
Hình 2.4.        -(4-axetamido-2-cloaryl)-
1,3,4-oxadiazol-2-thiol (IVf) 41
Hình 2.5-  44
Hình 2.6- 46
Hình 2.7
1
H- 46
Hình 2.8
1
H- 47
Hình 2.9
1
H- 47
Hình 2.10
13
C- 49
Hình 2.11 50
Hình 2.12 50



vii
Hình 2.13         5--axetamidoaryl)-

1,3,4-oxadiazol-2--brom--cloaxetanilit 54
Hình 2.14
1
H- 5--axetamido
aryl)-1,3,4-oxadiazol-2-th-brom--cloaxetanilit 55
Hình 2.15
1
H- 5--axetamido
aryl)- 1,3,4-oxadiazol-2--brom--cloaxetanilit 55
Hình 2.16     5--axetamidoaryl)-
1,3,4-oxadiazol-2- 4-brom--cloaxetanilit 56
Hình 2.17         5--
axetamidoaryl)-1,3,4-oxadiazol-2--brom--cloaxetanilit 57
    --axetamido
aryl)-1,3,4-oxadiazol-2--brom--cloaxetanilit 57
2-(N-arylcacboxamidometylthio)-5-(4-
axetamido--hidroxiaryl)-1,3,4-oxadiazol (V.3c) 69
Hình 2.20 
1
H-      2-(N--cloarylcacboxamido
metyl thio)-5--axetamido--hidroxiaryl)-1,3,4-oxadiazol (V.3c) 70
Hình 2.21 
13
C-    2-(N--cloarylcacboxamido
metylthio)-5--axetamido--hidroxiaryl)-1,3,4-oxadiazol (V.3c) 70
Hình 2.22       2-(N--cloarylcacboxamido
metylthio)-5--axetamido--hidroxiaryl)-1,3,4-oxadiazol (V.3c) 71
Hình 2.23
2
76

Hình 2.24      -(N--metoxiarylcacboxamido
metylthio)-5--axetamido--metylaryl)-1,3,4-oxadiazol 87
       -(N--nitroarylcacboxamidometyl-
thio)-5--axetamido--metylaryl)-1,3,4-oxadiazol 88
Hình 2.26 
1
H-    2-(N--metylarylcacboxamido
metylthio)-5--axetamidoaryl)-1,3,4-oxadiazol (V.1b) 90



viii
Hình 2.27 
1
H-    2-(N--nitroarylcacboxamido
metylthio)-5--axetamidoaryl)-1,3,4-oxadiazol (V.1f) 90
Hình 2.28 100
Hình 2.29.  V 109



ix
DANH MỤC CÁC BẢNG

 -oxadiazol 12
-oxadiazol-2-thiol 23

-g 36

1

H-
IIIa-g 37
B
-g 42

1
H--g 48
 51
 
5--axetamidoaryl)-2-(arylamino)-1,3,4-oxadiazol (VI.1) 60

5--axetamidoaryl)-2-arylamino-1,3,4-oxadiazol (VI.2) 61

5--axetamido--cloaryl)-2-arylamino-1,3,4-oxadiazol (VI.3) 62
  
1
H-     5--axetamidoaryl)-2-
arylamino-1,3,4-oxadiazol (VI.1) 63
  
1
H-      5--axetamidoaryl)-2-
arylamino-1,3,4-oxadiazol (VI.2) 64

1
H-5--axetamido--cloaryl)-
2-arylamino-1,3,4-oxadiazol (VI.3) 65
        --axetamidoaryl)-2-
(arylamino)-1,3,4-oxadiazol (VI.1) 66




x
--axetamido--cloaryl)-2-
arylamino-1,3,4-oxadiazol (VI.3) 67

 -(N-arylcacboxamidometylthio)-5--axetamidoaryl)-1,3,4-
oxadiazol (V.1a-81

  -(N-arylcacboxamidometylthio)-5--axetamido--metylaryl)-
1,3,4-oxadiazol (V.2a-82
 
  2-(N-arylcacboxamidometylthio)-5--axetamido--hidroxi
aryl)-1,3,4-oxadiazol (V.3a-i) 83

  -(N-arylcacboxamidometylthio)-5--axetamido--
hidroxiaryl)-1,3,4-oxadiazol (V.4a-84
 
  -(N-arylcacboxamidometylthio)-5--axetamido--cloaryl) -
1,3,4-oxadiazol (V.5a-85

  -(N-arylcacboxamidometylthio)-5--axetamido--brom
aryl)-1,3,4-oxadiazol (V.6a-86

1
H--h 92

1
H--i 93

1

H--i 94

1
H-V.4a-g 96

1
H-V.5a-i 97
   
1
H-      -(N-arylcacboxamido
metylthio)-5--axetamido--bromaryl)-1,3,4-oxadiazol (V.6a-h) 99



xi
-(N-arylcacboxamidometylthio)-5--
axetamidoaryl) -1,3,4-oxadiazol (V.1a-h) 101
 -(N-arylcacboxamidometylthio)- 5-
-axetamido--metylaryl)-1,3,4-oxadiazol (V.2a-102
-(N-arylcacboxamidometylthio)-
5--axetamido--hidroxiaryl)-1,3,4-oxadiazol (V.3a-i) 103
-(N-arylcacboxamidometylthio)-
5--axetamido--hidroxiaryl)-1,3,4-oxadiazol (V.4a-104
-(N-arylcacboxamidometylthio)-
5--axetamido--cloaryl)-1,3,4-oxadiazol (V.5a-105
-(N-arylcacboxamidometylthio)-5--
axetamido--bromaryl)-1,3,4-oxadiazol (V.6a-h) 106
  -(N-
arylcacboxamidometylthio)-5-(axetamidoaryl)-1,3,4-oxadiazol(V) 110
 129

  130
 130
         
 131





1
MỞ ĐẦU
-oxadiazol-2-thio

-oxadiazol-2-
49, 71], sát trùng [35]   5, 111],
21, 43], kháng viêm [21, 83-I [45,
64        
1,3,4-oxadiazol-2- 
- 
-oxadiazol-2-
8, 1
[8-oxadiazol-2-
              
[10
-2, 16].
-oxadiazol-2-thiol

 



thiol-óng-

- 

-I.
-oxadiazol-2-
  
cacbon disunfua [54, 56, 96, 115] 
2
và CSCl
2


   

-(axetamidoaryl)-1,3,4-oxadiazol-2-
 1,3,4-oxadiazol-2-





2




 
.











 , 


 , 













 5-
(axetamidoaryl)-1,3,4-oxadiazol-2-thiol; 









-cloaxetanilit 
2-(N-arylcacboxamidometylthio)-5-(axetamidoaryl)-1,3,4-oxadiazol; xác


              
thiocacbamoyl hóa các axetamidobenzoyl hidrazin 
5-(axetamidoaryl)-1,3,4-oxadiazol-2-thiol.
         5-(axetamidoaryl)-1,3,4-oxadiazol-2-
   -        2-(N-
arylcacboxamidometylthio)-5-(axetamidoaryl)-1,3,4-oxadiazol.
             5-(axetamidoaryl)-
1,3,4-oxadiazol-2-thiol và -


pháp Hóa  

 148 
  36 hình, 38
120  

H




3
CHƢƠNG 1: TỔNG QUAN
HÓA HỌC CÁC HỢP CHẤT 1,3,4-OXADIAZOL



N
O
N

1,3,4-oxadiazol
N
O
N

1,2,4-oxadiazol
N
O
N

1,2,5-oxadiazol
O
N
N

1,2,3-oxadiazol
Các vòng 1,3,4-, 1,2,4- và 1,2,5-g,
riêng vòng 1,2,3-
-oxadiazol không
    C. [7         etyl

focmylhidrazon format  
Sơ đồ 1.1
T
0
N
N
O
+
C
2
H
5
OH
NH
N
O
OC
2
H
5






-oxadiazol.
1.1. Các phƣơng pháp điều chế hợp chất 1,3,4-oxadiazol
-




4

-oxadiazol [70, 80, 114].
1.1.1. Điều chế từ các dẫn xuất của semicacbazit và thiosemicacbazit

1,3,4-oxadiazol. Lee
C.H. 61
môi d-2
-aryl-1,3,4-oxadiazol 1.2).
Sơ đồ 1.2
C
O
NH NH
C
R
O
OH
OH
N
O
N
R
(C
6
H
5
)
3

N / CCl
4
/ (C
2
H
5
)
3
N
CH
2
Cl
2
; 1-2h
R = C
6
H
5
; 4-ClC
6
H
4
; C
6
H
4
NH

 29, 30, 81, 114, 118  - 


2




-
64-77%. 
Sơ đồ 1.3
R
1
CONHNH
2
R
2
NCS
R
N
O
N
NHR
2
R
1
CONHNHCSNHR
2
I
2
/KI/NaOH

R

1
= C
6
H
5;
4-NO
2
C
6
H
4

2
= C
6
H
5
OCH
2
; 3-ClC
6
H
4
Dolman S.J. [30      -amino-1,3,4-  
yl clorua trong dung môi THF
:





5
Sơ đồ 1.4
N N
O
R
NH
R'
TsCl; pyridin
THF, 65-70
0
C; 20h
NH NH
R
O
NH
R'
S

R = CH
3
; C
2
H
5
, C(CH
3
)
3
; Ar



2
H
5

vòng thiosemica  -(N-4-flophenyl)-5-(4-phenylsulfonylphenyl)-
2-amin-1,3,4-oxadiazol 1.5)

Sơ đồ 1.5
N N
O
R
NH R'
NH NH
S
NH R'
O
R
HgO/ C
2
H
5
OH
T
0
; 8h
R = C
6
H
5

-SO
2
-C
6
H
4
; R '= 4-FC
6
H
4

     53, 115     -aryl-
1,3,4-

2
SO
4


Sơ đồ 1.6
Ar COCl
+
H
2
NHN C SR
S
Ar CONHNH C
S
SR
H

2
SO
4
(98%)
N
N
O
SH
Ar
Ar CONHNH C
S
SR
( or pyridin)
R = C
6
H
5
; 4-pyridyl




1.1.2. Điều chế dẫn xuất 1,3,4-oxadiazol từ hidrazon và các bazơ azometin
              
1,3,4-           75, 88, 101].
-



6


             
 -axetyl-1,3,4-oxadiazol [14, 22, 29, 36,
70   -Saysed A.W. [36]    
  2,5--1,3,4-

Sơ đồ 1.7
(CH
3
CO)
2
O
T
0
N
N
O
ROCH
2
SCH
2
N
O
N
R'
COCH
3
R' = D-glactopentitolyl
R = naphtyl
N

N
O
ROCH
2
SCH
2
NH
N
O
R'

 Dewangan D. [29
1-[2-(2-R-phenyl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-  
 
Sơ đồ 1.8
N
N
O
N
R
COCH
3
NH
N
R
N
O
(CH
3
CO)

2
O
4h
R = C
6
H
5
; 2-OHC
6
H
4
; 2-NH
2
C
6
H
4
; 2-COOHC
6
H
4


 1,3,4-oxaBhardwaj S. [22
  -[2-(2-R-phenyl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)- 
--12 phút.
 

-amino-5--1,3,4-oxadiazol [75, 88, 101]. Vjak
--1,3,4-

 -             
 1.9).





7
Sơ đồ 1.9
Br
2
/ CH
3
COOH
khuay 30 phút
R
N
O
N
NH
2
R
N NH
O
NH
2

R = H; p-ClC
6
H

4
; p-OHC
6
H
4

Sanjeev Kumar [5         
  
dung môi axetonitrin 1.9)-
1,3,4--90%.
Sơ đồ 1.10
R
N
O
N
NH
2
Pt; CH
3
CN
LiClO
4
R = 2-Cl(5-NO
2
)C
6
H
3
; 2,3-Cl
2

C
6
H
3
; 2-CH
3
C
6
H
4

R
N NH
O
NH
2
H

 
c60].
Mohammed I. A. [76-benzyliden-benzoyl
hidrazin -g
              -
diphenyl-1,3,4- 1.11.
Sơ đồ 1.11
N N
O
H
5
C

6
Ar
Cloramin-T
N NH
H
5
C
6
O
Ar
Ar = 4-ClC
6
H
5
; 4-BrC
6
H
5
; 4-NO
2
C
6
H
5



1.1.3. Điều chế dẫn xuất 1,3,4-oxadiazol từ các hidrazit của axit cacboxylic
-
           POCl

3
/axit, SOCl
2
,
BrCN, CS
2
/KOH



8

3

-Yar M. S.  [114

3
, sau 8

3

--1,3,4-

Sơ đồ 1.12
RCONHNH
2
POCl
3
R
N

O
N
R'
C
6
H
5
OCH
2
COOH
T
0
, 8h
R' = C
6
H
5
OCH
2
R = C
6
H
5
; 4-NO
2
C
6
H
4
; C

6
H
4
CH
2
; C
6
H
5
NHC
6
H
5

BDewangan D. và cng s [29u ch c dn
xut 2-aryl-5-pyridin-1,3,4-  a các nhóm th OH, NH
2
hoc COOH. Phn  c thc hin  nhi  120
0
C, trong 6 gi. Phn ng
c miêu t  1.13 
Sơ đồ 1.13
N
C
O
NHNH
2
+
RCOOH
POCl

3
6h, 120
0
C
N
N
O
N
R

R = C
6
H
5
; 2-OHC
6
H
4
; 2-NH
2
C
6
H
4
; 2-COOHC
6
H
4

  Patel N.B. [84           -

aminobenzoic và benzoyl hidrazin trong POCl
3
  1.14)     
-[5-(4-aryl)-1,3,4-oxadiazol-2-yl]benzenamin.
Sơ đồ 1.14
POCl
3
CONHNH
2
R
+
NH
2
COOH
T
0
, 7-10h
R
N
O
N
NH
2
R = 2-Cl; 4-Cl

          -amino-5-(imidazolyl)-1,3,4-
          
dioxan  NaCO
3
(0,1%), sau

 1.15) -50%.



9
Sơ đồ 1.15
N
N
CH
2
CONHNH
2
NH
2
R
N
N
NH
2
R
CH
2
N
O
N
NH
2
BrCN
Dioxan, NaHCO
3

R = H; CH
3


3
 
gian kéo dài (POCl
3

84, 108].

2

6, 80, 100, 115].
- 
1.16)           :    
2
  , nên

Sơ đồ 1.16
RCONHNH
2
+
KOH
+
CS
2
etanol
O
N

N
R
SK
O
N
N
R
SH
H
+

R = aryl
Tác Young R. D. [115] c
 

2
1.17).
Sơ đồ 1.17
RCONHNH
2
OH
R C
O
N NH
2
R C
O
N NH
2
C

S
S
S C S

anion enolat

-
2
S 1.18):
Sơ đồ 1.18



10

12-aryl-
1,3,4-oxadiazol-2- 1.19  sau:
Sơ đồ 1.19
1. KOH/etanol
2. H
+
R
CONHNH
2
+
CS
2
R
O
N

N
SH

R = p-NO
2
C
6
H
4;
p-ClC
6
H
4
; o-HOC
6
H
4
;
 [71p bis-1,3,4-d

 
Sơ đồ 1.20
KOH/etanol
CS
2
NH
2
NHCO(CH
2
)nCONHNH

2
SH
O
N
N
(CH
2
)n
O
N
N
SH
KOH
2C
6
H
5
CH
2
Br
H
5
C
6
H
2
CS
O
N
N

(CH
2
)n
O
N N
SCH
2
C
6
H
5


--


2
và CSCl
2



1.2. Tính chất của các dẫn xuất 1,3,4-oxadiazol
1.2.1. Cấu trúc của vòng 1,3,4-oxadiazol [97]
-
1.1.



11

N
N
O
N
N
O
N N
-
+
O
+
-

Hình 1.1. Các trạng thái cộng hưởng của hợp chất 1,3,4-oxadiazol
              
2
 
electron  

ng 1,3,4-oxadiazol có tính

Hyperchem 7.0 (Hình 1.2):

N
N
O
A
B
C
D

E

Góc
A
B
C
D
E
Giá tr, (
0
)
105.6
113.4
1020
113.4
105.6

Hình 1.2. Độ dài, góc liên kết và sự phân bố electron trong vòng 1,3,4-oxadiazol




                -
oxadiazol-2--oxadiazol-2-thion (Hình 1.3).
O
N
NH
S
H
O

N N
H
SH

Thion Thiol
Hình 1.3. Trạng thái hỗ biến thiol-thion của 1,3,4-oxadiazol-2-thiol



12



1
H-
6].
1.2.2. Tính chất vật lý
1,3,4-
o
C, không tan trong 
 -- 

        -phenyl-1,3,4-oxadiazol-2-   
 là 160-162
0
C [28, 91] trong khi bis 5-aryl-1,3,4- 

o
C [95].
Bảng 1.1. Nhiệt độ nóng chảy của một số dẫn xuất 1,3,4-oxadiazol

N
N
O
R
1
R

R
R
1
T
nc,

o
C [TLTK]
H
H
Cht lng (T
s
: 150
o
C)

H
SH
89-91 [41]
CH
3

SH

76-78 [41]
p-ClC
6
H
4

CH
2
Cl
85 [86]
C
6
H
5
-
SH
160-162 [28]
4-pyridyl
SH
272-273 [114]
-thiol 

thiol.1 là nhi -oxadiazol


×